Correlation of Sonographic Appearance of Chronic Liver Disease with Serological Findings of Hepatitis B and C in Multan City

Journal of Health and Medical Sciences

ISSN 2622-7258

Published: 06 June 2019

Correlation of Sonographic Appearance of Chronic Liver Disease with Serological Findings of Hepatitis B and C in Multan City

Babar Javaid, Syed Amir Gillani, Mustafa Ali Siddiqui, Ikram Akhtar, Sana Ali, Shazia Kausar, Tania Bashir, Hakeemullah Ghouri

Fatima Ultrasound Centre, Pakistan

pdf download

Download Full-Text Pdf

10.31014/aior.1994.02.02.38

Pages: 202-213

Keywords: Chronic Liver Disease, Hepatitis

Abstract

Liver cirrhosis is the irrecoverable disease of the liver, finally it causes necrosis of liver cells, as a result, change normal cells into an abnormal knot as well as structural abnormalities occur. It caused by many of reason, but here we discussed only by the hepatitis b virus and hepatitis b virus. The hazard of liver cirrhosis increased day by day. Recently liver cirrhosis prevalence of Pakistan was 13.5%. Sonography can easily diagnose the liver cirrhosis caused by hepatitis b and c virus. Objective: The object of this study to examine the analyses of ultra-sonographic diagnosis of liver cirrhosis in patients with chronic viral hepatitis B and C. Method: the cross-sectional study was conducted at Fatima ultrasound center. All age group patients with hepatitis B and C virus liver cirrhosis was included. Scanner GE Logic 5 and 7 Pro, DP-20 used for this study to examine the collaboration of liver cirrhosis. The liver cirrhosis associated hepatitis B virus and hepatitis C virus were analyzed on trans-abdominal by concave prob 2.5- 5MHz. Result: Total 376 patients determine to have hepatitis B and C virus cause liver cirrhosis were incorporate all age patients which a large portion of them was male the absolute level of liver cirrhosis was 46%. Conclusion: We observe that liver cirrhosis associated with hepatitis B and C virus more common in male than female. Rural areas are more effective by liver cirrhosis associated with hepatitis B and C virus.

References

  1. Gilani SA, Khan MA, Latif MZ, Malik AA, Arif M, Bukhari I. Epidemiological Study of Anti HCV Antibodies in Rural Punjab. Annals of King Edward Medical University. 2017;23(2).

  2. Asad M, Ahmed F, Zafar H, Farman S. Frequency and determinants of Hepatitis B and C virus in general population of Farash Town, Islamabad. Pakistan journal of medical sciences. 2015;31(6):1394.

  3. Papatheodoridis G, Thomas HC, Golna C, Bernardi M, Carballo M, Cornberg M, Dalekos G, Degertekin B, Dourakis S, Flisiak R, Goldberg D. Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference. Journal of viral hepatitis. 2016 1;23(S1):1-2.

  4. Kleiman RE, Goulet O, Mieli-Vergani G, Sanderson IR, Sherman PM, Shneider BL. Walker's pediatric gastrointestinal disease: physiology, diagnosis, management. Hamilton: BC Decker INC. 2008;2008:712-3.

  5. Sheen CL, Lamparelli H, Milne A, Green I, Ramage JK. Clinical features, diagnosis and outcome of acute portal vein thrombosis. Qjm. 2000 Aug 1;93(8):531-4.

  6. Xie B, Lin W, Ye J, Wang X, Zhang B, Xiong S, Li H, Tan G. DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1. Journal of Experimental & Clinical Cancer Research. 2015;34(1):101.

  7. McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatology international. 2009 Jun 1;3(2):334-42.

  8. Xie B, Lin W, Ye J, Wang X, Zhang B, Xiong S, Li H, Tan G. DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1. Journal of Experimental & Clinical Cancer Research. 2015;34(1):101.

  9. Patriquin H, Lafortune M, Burns PN, Dauzat M. Duplex Doppler examination in portal hypertension: technique and anatomy. American Journal of Roentgenology. 1987 1;149(1):71-6.

  10. Qiao Y, Lu S, Xu Z, Li X, Zhang K, Liu Y, Zhao L, Chen R, Si L, Lin S, Xu D. Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBsAg/anti-HBs. Oncotarget. 2017 Sep 22;8(37):61719.

  11. Xie B, Lin W, Ye J, Wang X, Zhang B, Xiong S, Li H, Tan G. DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1. Journal of Experimental & Clinical Cancer Research. 2015;34(1):101.

  12. Zheng RQ, Wang QH, Lu MD, Xie SB, Ren J, Su ZZ, Cai YK, Yao JL. Liver fibrosis in chronic viral hepatitis: an ultrasonographic study. World journal of gastroenterology. 2003 15;9(11):2484.

  13. Realdi G, Fattovich G, Hadziyannis S, Schalm SW, Almasio P, Sanchez-Tapias J, Christensen E, Giustina G, Noventa F. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. Journal of hepatology. 1994 1;21(4):656-66.

  14. Schuppan D, Afdhal NH. Liver cirrhosis. The Lancet. 2008 Mar 8;371(9615):838-51.

  15. McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatology international. 2009 Jun 1;3(2):334-42.

  16. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. The Lancet infectious diseases. 2005 1;5(9):558-67.

  17. Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009 May 1;49(S5).

  18. Sun L, Guan YS, Pan WM, Chen GB, Luo ZM, Wei JH, Wu H. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma. World journal of gastroenterology: WJG. 2008 Feb 28;14(8):1212.

  19. Sharma P, Kumar R, Singh H, Jeph S, Patnecha M, Reddy RM, Naswa N, Bal C, Malhotra A. Imaging thrombus in cancer patients with FDG PET–CT. Japanese journal of radiology. 2012 1;30(2):95-104.

  20. Lee EY, Khong PL. The value of 18F-FDG PET/contrast-enhanced CT in detection of tumor thrombus. Clinical nuclear medicine. 2013 1;38(2):e60-5.

  21. Sopov V, Bernstine H, Stern D, Yefremov N, Sosna J, Groshar D. The metabolic spectrum of venous thrombotic disorders found on PET/CT. American Journal of Roentgenology. 2009 Dec;193(6): W530-9.

  22. Sharma P, Kumar R, Jeph S, Karunanithi S, Naswa N, Gupta A, Malhotra A. 18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus?. Nuclear medicine communications. 2011 Sep 1;32(9):782-8.

About Us

The Asian Institute of Research is an online and open-access platform to publish recent research and articles of scholars worldwide. Founded in 2018 and based in Indonesia, the Institute serves as a platform for academics, educators, scholars, and students from Asia and around the world, to connect with one another. The Institute disseminates research that is proven or predicted to be of significant influence for the general public.

Contact Us

Please send all inquiries to the email:

editorial@asianinstituteofresearch.org

Business Address:

5th Floor, Kavling 507, Fajar Graha Pena Tower, Jl. Urip Sumohardjo No.20, Makassar, Indonesia 90234

Copyright © 2018 The Asian Institute of Research. All rights reserved

Stay Connected

  • Instagram - Black Circle
  • Facebook - Black Circle
  • LinkedIn - Black Circle